[go: up one dir, main page]

ES2059990T3 - Procedimiento de preparacion de un producto antimicrobiano en particulas, producto antimicrobiano obtenido y aplicaciones. - Google Patents

Procedimiento de preparacion de un producto antimicrobiano en particulas, producto antimicrobiano obtenido y aplicaciones.

Info

Publication number
ES2059990T3
ES2059990T3 ES90200971T ES90200971T ES2059990T3 ES 2059990 T3 ES2059990 T3 ES 2059990T3 ES 90200971 T ES90200971 T ES 90200971T ES 90200971 T ES90200971 T ES 90200971T ES 2059990 T3 ES2059990 T3 ES 2059990T3
Authority
ES
Spain
Prior art keywords
procedure
antimicrobial product
applications
enzyme
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90200971T
Other languages
English (en)
Inventor
Daniel Samain
Frederique Nguyen
Michel Francois Degre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Serae Laboratoires SA
Original Assignee
Bio Serae Laboratoires SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Serae Laboratoires SA filed Critical Bio Serae Laboratoires SA
Application granted granted Critical
Publication of ES2059990T3 publication Critical patent/ES2059990T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/783—Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCEDIMIENTO PARA LA OBTENCION DE UN PRODUCTO PARTICULAR ANTIMICROBIANO A PARTIR DE UN SISTEMA LP ENZIMA LACTOPEROXIDASA/DONADOR DE OXIGENO/EVENTUALMENTE SUBSTRATO OXIDABLE. EL PROCEDIMIENTO CONSISTE EN FONDEAR EL ENZIMA LACTOPEROXIDASA EN UN VECTOR PARTICULAR QUE CONTIENE UNA RED POLISACARIDA, UNA PRIMERA CAPA LIPIDA Y UNA SEGUNDA CAPA FOSFOLIPIDA, DE MODO QUE LAS MOLECULAS DE ENZIMA ESTAN INSERTADAS EN ESTA SEGUNDA CAPA Y/O EN LA PRIMERA. EL PRODUCTO DE ACUERDO CON LA INVENCION SE OBTIENE CONDICIONANDO DESPUES EN MEDIO NO ACUOSO EL VECTOR PARTICULAR PRECITADO Y LAS MOLECULAS DEL SISTEMA LP NO INTEGRADAS EN DICHO VECTOR. EL PROCEDIMIENTO DE LA INVENCION PERMITE AJUSTAR LA DIFUSIBILIDAD DEL PRODUCTO Y SU MOVILIDAD EN FUNCION DE LAS APLICACIONES, SIN DESNATURALIZACION DEL SISTEMA LP
ES90200971T 1989-05-12 1990-04-19 Procedimiento de preparacion de un producto antimicrobiano en particulas, producto antimicrobiano obtenido y aplicaciones. Expired - Lifetime ES2059990T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906668A FR2646777B1 (fr) 1989-05-12 1989-05-12 Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications

Publications (1)

Publication Number Publication Date
ES2059990T3 true ES2059990T3 (es) 1994-11-16

Family

ID=9381881

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90200971T Expired - Lifetime ES2059990T3 (es) 1989-05-12 1990-04-19 Procedimiento de preparacion de un producto antimicrobiano en particulas, producto antimicrobiano obtenido y aplicaciones.

Country Status (9)

Country Link
US (1) US5206156A (es)
EP (1) EP0397227B1 (es)
JP (1) JP3003045B2 (es)
KR (1) KR0149997B1 (es)
AT (1) ATE96680T1 (es)
CA (1) CA2014847C (es)
DE (1) DE69004329T2 (es)
ES (1) ES2059990T3 (es)
FR (1) FR2646777B1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5756090A (en) * 1991-02-21 1998-05-26 Eoe, Inc. Oxygen activatable formulations for disinfection or sterilization
US5888505A (en) * 1991-02-21 1999-03-30 Eoe, Inc. Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system
KR930703012A (ko) * 1991-02-21 1993-11-29 잭슨 티. 스티븐스 쥬니어 폴로라의 조절 및 감염의 치료를 위한 방법 및 이것의 조성물
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
US5565197A (en) * 1991-02-21 1996-10-15 Exoxemis, Inc. Method which utilizes a haloperoxidase composition to inhibit the growth of microorganisms which cause sexually transmitted diseases
US5534501A (en) * 1991-06-04 1996-07-09 A Et S Biovecteurs Particle for use as a milk fat globule substitute, composition containing same and process for the preparation of said particle
US5736371A (en) * 1991-06-04 1998-04-07 A Et S Biovecteurs Biodegradable particulate vector for transporting molecules having biological activity
FR2677249B1 (fr) * 1991-06-04 1995-03-17 Biovecteurs As Vecteur particulaire biodegradable et procede de synthese.
FR2677272B1 (fr) * 1991-06-05 1995-03-03 Biovecteurs As Vecteur particulaire a tropisme selectif, procede de preparation et composition pharmaceutique.
US5747078A (en) * 1991-06-11 1998-05-05 Gist-Brocades, N.V. Longterm antimicrobial activity obtained by sustained release of hydrogen peroxide
WO1992022221A1 (en) * 1991-06-11 1992-12-23 Gist-Brocades N.V. Long-term antimicrobial activity obtained by sustained release of hydrogen peroxide
GB9200891D0 (en) * 1992-01-16 1992-03-11 Mann Stephen P Formulation of microorganisms
AU665381B2 (en) * 1992-01-23 1996-01-04 Morinaga Milk Industry Company Limited Antibacterial agent and treatment of article therewith
FR2695034B1 (fr) 1992-09-01 1994-10-07 Oreal Composition cosmétique ou pharmaceutique comprenant en association une peroxydase et un agent anti-oxygène singulet.
CA2192681A1 (en) * 1994-07-14 1996-02-01 Margarete Enzmann Granular formulation containing microorganisms, a process for the preparation and the use thereof
ATE412668T1 (de) 1995-08-23 2008-11-15 Univ British Columbia Antimikrobielle kationische peptide und methoden zu ihrer identifizierung
SE506529C2 (sv) * 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
FR2750575B1 (fr) * 1996-07-04 1998-11-13 Labeyrie Sa Procede de decontamination de produits d'origine aquacole
CA2373485A1 (en) * 1999-05-14 2000-11-23 Peter Francis Fennessy Microbially resistant compositions
US6172040B1 (en) * 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
FR2825373B1 (fr) * 2001-05-31 2004-04-30 Tmi Europ Procede de production enzymatique d'un agent de traitement a l'etat fluide
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
CN1719003B (zh) 2004-07-07 2010-05-26 株式会社东芝 用于汽轮机的主汽阀
US8945540B2 (en) * 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
BR112014000542A2 (pt) 2011-07-11 2017-02-14 Exoxemis Inc composições de peroxidase eosinofílica e métodos de uso das mesmas
RU2665094C2 (ru) * 2013-08-06 2018-08-28 Биенка Н.В. Противомикробная композиция и ее применение для консервирования пищевых продуктов
GB201417248D0 (en) * 2014-09-30 2014-11-12 Blueberry Therapeutics Ltd Compostion and methods of treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE23523E (en) * 1952-07-22 Enzymaticaiay deoxygenated
US2765233A (en) * 1953-05-29 1956-10-02 Sarett Enzyme-treated sheet product and article wrapped therewith
US3242051A (en) * 1958-12-22 1966-03-22 Ncr Co Coating by phase separation
US4233290A (en) * 1979-03-01 1980-11-11 Spa-Societa Prodotti Antibiotici, S.P.A. Method of treating domestic animals
US4486408A (en) * 1981-04-07 1984-12-04 Kiel Johnathan L Insoluble crosslinked cytotoxic oxidase-peroxidase system
LU85910A1 (fr) * 1985-05-22 1986-12-05 Oleofina Sa Procede pour eliminer l'oxygene dans les aliments et les boissons,et composition enzymatique utilisee a cet effet
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
FR2600250B1 (fr) * 1986-06-23 1989-11-24 Bio Serae Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee
IT1197924B (it) * 1986-10-28 1988-12-21 Prodotti Antibiotici Spa Procedimento per la preparazione di alimenti di origine animale
SE8701839L (sv) * 1987-05-05 1988-11-06 Ewos Ab Livs- och fodermedel
JPS6447364A (en) * 1987-08-17 1989-02-21 Suntory Ltd Food and drink containing lactate monooxygenase
JPH0262829A (ja) * 1988-05-18 1990-03-02 Nippon Kayaku Co Ltd 虚血に基づく傷害の予防及び治療剤
FR2631826B1 (fr) * 1988-05-27 1992-06-19 Centre Nat Rech Scient Vecteur particulaire utile notamment pour le transport de molecules a activite biologique et procede pour sa preparation

Also Published As

Publication number Publication date
KR900017571A (ko) 1990-12-19
KR0149997B1 (ko) 1998-10-15
US5206156A (en) 1993-04-27
CA2014847A1 (fr) 1990-11-12
EP0397227A1 (fr) 1990-11-14
FR2646777B1 (fr) 1993-09-03
JP3003045B2 (ja) 2000-01-24
JPH03193708A (ja) 1991-08-23
ATE96680T1 (de) 1993-11-15
EP0397227B1 (fr) 1993-11-03
DE69004329D1 (de) 1993-12-09
DE69004329T2 (de) 1994-05-19
CA2014847C (fr) 2000-06-13
FR2646777A1 (fr) 1990-11-16

Similar Documents

Publication Publication Date Title
ES2059990T3 (es) Procedimiento de preparacion de un producto antimicrobiano en particulas, producto antimicrobiano obtenido y aplicaciones.
Wallace et al. Determination of color, pigment, and phenolic stability in yogurt systems colored with nonacylated anthocyanins from Berberis boliviana L. as compared to other natural/synthetic colorants
Rymaszewski et al. The role of neutrophil myeloperoxidase in models of lung tumor development
Hamad et al. Metabolic analysis of various date palm fruit (Phoenix dactylifera L.) cultivars from Saudi Arabia to assess their nutritional quality
Bräunlich et al. Extracts, anthocyanins and procyanidins from Aronia melanocarpa as radical scavengers and enzyme inhibitors
Ozgen et al. Modified 2, 2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) method to measure antioxidant capacity of selected small fruits and comparison to ferric reducing antioxidant power (FRAP) and 2, 2 ‘-diphenyl-1-picrylhydrazyl (DPPH) methods
Sasaki et al. Antioxidant activity of water-soluble fractions of salmon spermary tissue
BR0014087A (pt) Composições com pérolas de caroteno - xantofila estáveis e métodos de uso
BR0214380A (pt) Produto para uso em agricultura ou horticultura
Napolitano et al. Chlorella sorokiniana dietary supplementation increases antioxidant capacities and reduces ros release in mitochondria of hyperthyroid rat liver
KR870003793A (ko) 트롬빈 제재의 방법
FI830897L (fi) Foerfarande foer framstaellning av nya konjugat, vari enzym och antikropp aer bundna vid varandra medelst en kovalent bindning
Crockett et al. Cholesterol levels explain inverse compensation of membrane order in brush border but not homeoviscous adaptation in basolateral membranes from the intestinal epithelia of rainbow trout
Sonklin et al. Functional characterization of mung bean meal protein-derived antioxidant peptides
Sudharshan et al. Antibacterial potential of a basic phospholipase A 2 (VRV-PL-VIIIa) from Daboia russelii pulchella (Russell’s viper) venom
EP0247730A3 (en) Antibodies, their preparation and use and products containing them
Hurt et al. Tributyltin and dibutyltin alter secretion of tumor necrosis factor alpha from human natural killer cells and a mixture of T cells and natural killer cells
NO974564L (no) Karbohydratmodifiserte cytostatika
Yue et al. Functional elucidation of Nemopilema nomurai and Cyanea nozakii nematocyst venoms’ lytic activity using mass spectrometry and zymography
Oliveira et al. Toxicity of South American snake venoms measured by an in vitro cell culture assay
Baratzadeh et al. Antioxidant peptides obtained from goose egg white proteins by enzymatic hydrolysis
Marín-Morales et al. Biological activity of extracts and hydrolysates from early-and adult-stage edible grasshopper Sphenarium purpurascens
Ibrahim et al. Increased carbon dioxide concentration improves the antioxidative properties of the Malaysian herb Kacip Fatimah (Labisia pumila Blume)
Stanca et al. Development of functional foods: A comparative study on the polyphenols and anthocyanins content in chokeberry and blueberry pomace extracts and their antitumor properties
Gergely et al. Selenium species in aqueous extracts of alfalfa sprouts by two-dimensional liquid chromatography coupled to inductively coupled plasma mass spectrometry and electrospray mass spectrometry detection

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 397227

Country of ref document: ES